Clinical Trial Update: Low Dose Metronomic Poly-chemotherapy for Metastatic CRC [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluates low-dose metronomic poly-chemotherapy for metastatic colorectal cancer and has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Snippet

Sponsor: HaEmek Medical Center, Israel | Conditions: Colorectal Cancer | Phase 2 | Status: COMPLETED